We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Show more
Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
4 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
12 | -1.11 | -22.2668004012 | 4.985 | 5.705 | 3.15 | 918408 | 3.96042018 | CS |
26 | -1.125 | -22.5 | 5 | 9.395 | 3.15 | 1253862 | 5.15987946 | CS |
52 | -10.8 | -73.594548552 | 14.675 | 23.5 | 3.15 | 811865 | 6.24657842 | CS |
156 | -116.375 | -96.7775467775 | 120.25 | 227.7725 | 3.15 | 708553 | 17.12910906 | CS |
260 | -340.125 | -98.8735465116 | 344 | 359.75 | 3.15 | 578863 | 29.01959287 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions